AT
ADvantage Therapeutics, Inc.
SEC filingOther Health Care · Miami, FL
Amount raised$13.7Msold at filing
Total offering$25.4M$11.7M still open
Investors in the raise24count reported to the SEC
FiledJul 28, 2025first sale Jun 28, 2023
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Walter B. SchmidtDirector
Agustin Fernandez Santana IIIExecutive Officer, Director
Jeffrey B. MaddenExecutive Officer, Director
David B. BuchsbaumExecutive Officer
Frank B. MattnerDirector
Executive officers, directors and promoters as listed on the Form D.